24.3
体液性免疫反応は、血液やリンパ液などの細胞外液中に存在する病原体を標的とする免疫反応です。抗体は侵入してきた病原体を中和、オプソニン化、補体系の活性化などの複数の防御機構を介して破壊します。抗体の産生に障害がある患者は、一般的な病原体や異常な病原体による重篤な感染症に頻繁に見舞われます。
他の適応免疫反応、つまり体液性免疫である免疫系は、血液やリンパ液を含む細胞外液を 循環する病原体を標的とします。バクテリアなどの侵入病原体は、病原体 バクテリア表面の抗原を認識するB細胞と呼ばれる 特定の白血球によって検出されます。抗原 一旦活性化すると B細胞が増殖し、形質細胞に分化します。血液が流れる方向 それから体内を循環し 防衛機制を活性化する何百万もの抗体を分泌します。その方法のひとつは、病原体の表面上の抗原に結合する抗体が、宿主細胞に感染する能力を妨害し、病原体を不活性化または中和します。それらはまた、マクロファージまたは好中球などの食細胞による 貪食・破壊するため病原体を オプソニン化またはタグ付けすることもできます。最後に、抗体は補体系、すなわちオプソニン作用および病原体の破壊を さらに強めるタンパク質の複合体を 活性化することができます。病原体が破壊されたとしても、活性化されたB細胞の中には形質細胞の代わりに メモリーB細胞に分化するものがあります。これらのメモリーB細胞は感染がなくなった後も 少量の抗体を産生し続けるのです。同じ病原体が体内に再び侵入すると、これらの循環抗体はそれを標的にし、すぐに破壊することができるのです。
View the full transcript and gain access to JoVE Core videos
Q1: What are the main defense mechanisms antibodies use to destroy pathogens?
Antibodies destroy pathogens through three primary mechanisms: neutralization, opsonization, and complement system activation. Neutralization occurs when antibodies bind to pathogen surfaces and interfere with their ability to infect host cells. Opsonization tags pathogens for destruction by phagocytes like macrophages and neutrophils. The complement system, a cascade of over 30 proteins, further enhances pathogen destruction and triggers inflammatory responses.
Q2: How do B cells recognize and respond to invading pathogens?
B cells detect pathogens by recognizing specific antigens on bacterial surfaces through their B cell receptors. Upon antigen binding and receiving a second signal from helper T cells or the antigen itself, B cells become activated and form germinal centers. In these centers, B cells proliferate and differentiate into plasma cells that secrete millions of antibodies, or into memory B cells that provide long-term immunity.
Q3: What is the difference between plasma cells and memory B cells?
Plasma cells are short-lived B cells that actively secrete large quantities of genetically identical antibodies circulating throughout the bloodstream. Memory B cells are long-lived cells that produce antibodies bound to their surface and enable rapid, stronger immune responses upon reexposure to the same pathogen. Memory B cells persist long after infection clears, providing lasting immunity.
Q4: Why do patients with antibody deficiencies suffer from frequent infections?
Patients with antibody deficiencies like hypogammaglobulinemia lack sufficient antibodies to neutralize, opsonize, or activate complement against pathogens. Without adequate antibody production, pathogens circulating in blood and lymph evade destruction, leading to frequent ear, sinus, pulmonary, and gastrointestinal infections. Infections by unusual pathogens become severe, and common pathogen infections are often recurrent.
Q5: How does the humoral immune response target pathogens in body fluids?
The humoral immune response targets pathogens circulating in extracellular fluids like blood and lymph. B cells detect specific antigens on pathogen surfaces and differentiate into plasma cells that secrete antibodies. These antibodies circulate throughout the body, binding to antigens and activating defense mechanisms including neutralization, opsonization, and complement system activation.
Q6: What role do memory B cells play in secondary immune responses?
Memory B cells persist long after initial infection and continue producing small amounts of antibody. When the same pathogen reenters the body, circulating antibodies from memory B cells immediately target it for destruction, enabling faster and stronger immune responses. This mechanism provides long-term protection against reinfection by previously encountered pathogens.
Q7: How does the complement system enhance pathogen destruction?
The complement system is a sequential cascade of over 30 proteins activated by antibodies binding to antigens. These proteins opsonize pathogens for destruction by macrophages and neutrophils, induce inflammatory responses that recruit additional immune cells, and promote lysis of pathogen membranes. This multi-step process significantly amplifies the antibody-mediated immune response.